Liver Injury Is Most Commonly Due to Hepatic Metastases Rather Than Drug Hepatotoxicity During Pembrolizumab Immunotherapy
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15413
Full Text
Open PDFAbstract
Available in full text
Date
July 15, 2019
Authors
Publisher
Wiley